BACKGROUND: NOTCH signaling is involved in every step of metazoan development and maintenance of adult tissue homeostasis. It is frequently deregulated by mutations and overexpression in different cancer types including solid tumors such as breast cancer. Another common feature of solid tumors is hypoxia, which occurs due to defective or insufficient vascularization. Hypoxia-inducible factors (HIFs) are key regulators of the homeostatic response to low oxygen levels. HIF-1α is overexpressed in many solid tumors, including breast cancer. Hypoxia-induced stabilization of HIF transcription factors has been shown to lead to NOTCH activation in vitro in different contexts and tissues, causing differentiation arrest and induction of proliferation and migration. METHODS: Since the link between HIF-1α and NOTCH signalling has hardly been studied, we set out to closely investigate associations between the expression of HIF-1α and NOTCH pathway members in primary and metastatic human breast cancer specimens and their prognostic value. RESULTS: Co-expression of NOTCH1 intracellular domain (N1ICD) and HIF-1α was associated with a high grade and a high proliferation rate in invasive breast cancer. HIF-1α expression was low in classic, but high in pleomorphic lobular cancers, which also frequently showed stromal HIF-1α expression. NOTCH1 pathway activation was prognostically unfavorable. CONCLUSION: In breast cancer, NOTCH pathway activation appears to be associated with a poor prognosis, but NOTCH and HIF signaling do not seem to be functionally associated.
BACKGROUND: NOTCH signaling is involved in every step of metazoan development and maintenance of adult tissue homeostasis. It is frequently deregulated by mutations and overexpression in different cancer types including solid tumors such as breast cancer. Another common feature of solid tumors is hypoxia, which occurs due to defective or insufficient vascularization. Hypoxia-inducible factors (HIFs) are key regulators of the homeostatic response to low oxygen levels. HIF-1α is overexpressed in many solid tumors, including breast cancer. Hypoxia-induced stabilization of HIF transcription factors has been shown to lead to NOTCH activation in vitro in different contexts and tissues, causing differentiation arrest and induction of proliferation and migration. METHODS: Since the link between HIF-1α and NOTCH signalling has hardly been studied, we set out to closely investigate associations between the expression of HIF-1α and NOTCH pathway members in primary and metastatic humanbreast cancer specimens and their prognostic value. RESULTS: Co-expression of NOTCH1 intracellular domain (N1ICD) and HIF-1α was associated with a high grade and a high proliferation rate in invasive breast cancer. HIF-1α expression was low in classic, but high in pleomorphic lobular cancers, which also frequently showed stromal HIF-1α expression. NOTCH1 pathway activation was prognostically unfavorable. CONCLUSION: In breast cancer, NOTCH pathway activation appears to be associated with a poor prognosis, but NOTCH and HIF signaling do not seem to be functionally associated.
Authors: Barbara Chiavarina; Diana Whitaker-Menezes; Gemma Migneco; Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Anthony Howell; Herbert B Tanowitz; Mathew C Casimiro; Chenguang Wang; Richard G Pestell; Philip Grieshaber; Jaime Caro; Federica Sotgia; Michael P Lisanti Journal: Cell Cycle Date: 2010-09-04 Impact factor: 4.534
Authors: R Bos; H Zhong; C F Hanrahan; E C Mommers; G L Semenza; H M Pinedo; M D Abeloff; J W Simons; P J van Diest; E van der Wall Journal: J Natl Cancer Inst Date: 2001-02-21 Impact factor: 13.506
Authors: M M Vleugel; A E Greijer; A Shvarts; P van der Groep; M van Berkel; Y Aarbodem; H van Tinteren; A L Harris; P J van Diest; E van der Wall Journal: J Clin Pathol Date: 2005-02 Impact factor: 3.411
Authors: Clay L Efferson; Christopher T Winkelmann; Christopher Ware; Timothy Sullivan; Saverio Giampaoli; Jennifer Tammam; Shailendra Patel; Giuseppe Mesiti; John F Reilly; Raymond E Gibson; Carolyn Buser; Timothy Yeatman; Domenico Coppola; Christopher Winter; Edwin A Clark; Giulio F Draetta; Peter R Strack; Pradip K Majumder Journal: Cancer Res Date: 2010-03-02 Impact factor: 12.701
Authors: Cecilia Sahlgren; Maria V Gustafsson; Shaobo Jin; Lorenz Poellinger; Urban Lendahl Journal: Proc Natl Acad Sci U S A Date: 2008-04-21 Impact factor: 11.205
Authors: Sanne Weijzen; Paola Rizzo; Mike Braid; Radhika Vaishnav; Suzanne M Jonkheer; Andrei Zlobin; Barbara A Osborne; Sridevi Gottipati; Jon C Aster; William C Hahn; Michael Rudolf; Kalliopi Siziopikou; W Martin Kast; Lucio Miele Journal: Nat Med Date: 2002-08-19 Impact factor: 53.440
Authors: Laurien D C Hoefnagel; Marc J van de Vijver; Henk-Jan van Slooten; Pieter Wesseling; Jelle Wesseling; Pieter J Westenend; Joost Bart; Cornelis A Seldenrijk; Iris D Nagtegaal; Joost Oudejans; Paul van der Valk; Petra van der Groep; Elisabeth G E de Vries; Elsken van der Wall; Paul J van Diest Journal: Breast Cancer Res Date: 2010-09-23 Impact factor: 6.466
Authors: Arthur Adams; Aram S A van Brussel; Jeroen F Vermeulen; Willem P Th M Mali; Elsken van der Wall; Paul J van Diest; Sjoerd G Elias Journal: BMC Cancer Date: 2013-11-10 Impact factor: 4.430
Authors: Erik W J Mollen; Jonathan Ient; Vivianne C G Tjan-Heijnen; Liesbeth J Boersma; Lucio Miele; Marjolein L Smidt; Marc A G G Vooijs Journal: Front Oncol Date: 2018-11-20 Impact factor: 6.244
Authors: Yeji An; Jessica R Adams; Daniel P Hollern; Anthony Zhao; Stephen G Chang; Miki S Gams; Philip E D Chung; Xiaping He; Rhea Jangra; Juhi S Shah; Joanna Yang; Lauren A Beck; Nandini Raghuram; Katelyn J Kozma; Amanda J Loch; Wei Wang; Cheng Fan; Susan J Done; Eldad Zacksenhaus; Cynthia J Guidos; Charles M Perou; Sean E Egan Journal: Cell Rep Date: 2018-10-16 Impact factor: 9.423